O	0	6	Effect
O	7	9	of
B-intervention	10	21	mindfulness
I-intervention	21	22	-
I-intervention	22	27	based
I-intervention	28	34	stress
I-intervention	35	44	reduction
O	45	47	on
B-condition	48	53	sleep
I-condition	54	61	quality
O	61	62	:
O	63	70	results
O	71	73	of
O	74	75	a
O	76	86	randomized
O	87	92	trial
O	93	98	among
B-ethinicity	99	105	Danish
O	106	112	breast
O	113	119	cancer
O	120	128	patients
O	128	129	.

O	130	133	The
O	134	144	prevalence
O	145	147	of
O	148	153	sleep
O	154	165	disturbance
O	166	168	is
O	169	173	high
O	174	179	among
O	180	186	cancer
O	187	195	patients
O	195	196	,
O	197	200	and
O	201	204	the
O	205	210	sleep
O	211	219	problems
O	220	224	tend
O	225	227	to
O	228	232	last
O	233	236	for
O	237	242	years
O	243	248	after
O	249	252	the
O	253	256	end
O	257	259	of
O	260	269	treatment
O	269	270	.

O	271	273	As
O	274	278	part
O	279	281	of
O	282	283	a
O	284	289	large
O	290	300	randomized
O	301	311	controlled
O	312	320	clinical
O	321	326	trial
O	327	328	(
O	328	331	the
O	332	336	MICA
O	337	342	trial
O	342	343	,
O	344	355	NCT00990977
O	355	356	)
O	357	359	of
O	360	363	the
O	364	370	effect
O	371	373	of
O	374	385	mindfulness
O	385	386	-
O	386	391	based
O	392	398	stress
O	399	408	reduction
O	409	410	(
O	410	414	MBSR
O	414	415	)
O	416	418	on
O	419	432	psychological
O	433	436	and
O	437	444	somatic
O	445	453	symptoms
O	454	459	among
O	460	466	breast
O	467	473	cancer
O	474	482	patients
O	482	483	,
O	484	487	the
O	488	491	aim
O	492	494	of
O	495	498	the
O	499	506	current
O	507	512	study
O	513	516	was
O	517	519	to
O	520	528	evaluate
O	529	532	the
O	533	539	effect
O	540	542	of
O	543	547	MBSR
O	548	550	on
O	551	554	the
O	555	564	secondary
O	565	572	outcome
O	572	573	,
B-outcome-Measure	574	575	'
I-outcome-Measure	575	580	sleep
I-outcome-Measure	581	588	quality
I-outcome-Measure	588	589	'
O	589	590	.

O	591	592	A
O	593	598	total
O	599	601	of
B-total-participants	602	605	336
B-eligibility	606	611	women
I-eligibility	612	620	operated
I-eligibility	621	623	on
I-eligibility	624	627	for
I-eligibility	628	634	breast
I-eligibility	635	641	cancer
I-eligibility	642	647	stage
I-eligibility	648	649	I
I-eligibility	649	650	-
I-eligibility	650	653	III
I-eligibility	654	655	3
I-eligibility	655	656	-
I-eligibility	656	658	18
I-eligibility	659	665	months
I-eligibility	666	676	previously
O	677	681	were
O	682	692	randomized
O	693	695	to
O	696	700	MBSR
O	701	702	(
O	702	703	n
O	704	705	=
B-intervention-participants	706	709	168
O	709	710	)
O	711	713	or
B-control	714	723	treatment
I-control	724	726	as
I-control	727	732	usual
O	733	734	(
O	734	735	n
O	736	737	=
B-control-participants	738	741	168
O	741	742	)
O	742	743	;
O	744	748	both
O	749	755	groups
O	756	764	received
O	765	773	standard
O	774	782	clinical
O	783	787	care
O	787	788	.

O	789	792	The
O	793	805	intervention
O	806	815	consisted
O	816	818	of
O	819	821	an
O	822	827	eight
O	827	828	-
O	828	832	week
O	833	837	MBSR
O	838	845	program
O	846	847	(
O	847	853	psycho
O	853	854	-
O	854	863	education
O	863	864	,
O	865	875	meditation
O	876	879	and
O	880	886	gentle
O	887	891	yoga
O	891	892	)
O	892	893	.

O	894	899	Sleep
O	900	907	quality
O	908	911	was
O	912	920	assessed
O	921	923	on
O	924	927	the
O	928	935	Medical
O	936	943	Outcome
O	944	949	Study
O	950	955	sleep
O	956	961	scale
O	962	964	at
O	965	973	baseline
O	973	974	,
O	975	980	after
O	981	984	the
O	985	997	intervention
O	998	1001	and
O	1002	1004	at
O	1005	1008	six
O	1008	1009	-
O	1010	1013	and
O	1014	1016	12
O	1016	1017	-
O	1017	1023	months
O	1023	1024	'
O	1025	1031	follow
O	1031	1032	-
O	1032	1034	up
O	1034	1035	.

O	1036	1039	The
B-outcome	1040	1044	mean
I-outcome	1045	1050	sleep
I-outcome	1051	1058	problem
I-outcome	1059	1065	scores
O	1066	1070	were
O	1071	1084	significantly
O	1085	1090	lower
O	1091	1093	in
O	1094	1097	the
O	1098	1102	MBSR
O	1103	1108	group
O	1109	1113	than
O	1114	1116	in
O	1117	1125	controls
O	1126	1137	immediately
O	1138	1143	after
O	1144	1147	the
O	1148	1160	intervention
O	1160	1161	.

O	1162	1170	Quantile
O	1171	1181	regression
O	1182	1190	analyses
O	1191	1197	showed
O	1198	1202	that
O	1203	1206	the
O	1207	1213	effect
O	1214	1217	was
O	1218	1231	statistically
O	1232	1243	significant
O	1244	1248	only
O	1249	1252	for
O	1253	1256	the
O	1257	1269	participants
O	1270	1281	represented
O	1282	1284	by
O	1285	1288	the
O	1289	1294	lower
O	1295	1305	percentile
O	1306	1308	of
O	1309	1315	change
O	1316	1323	between
O	1324	1332	baseline
O	1333	1336	and
O	1337	1341	post
O	1341	1342	-
O	1342	1354	intervention
O	1354	1355	,
O	1356	1357	i
O	1357	1358	.
O	1358	1359	e
O	1359	1360	.
O	1361	1366	those
O	1367	1370	who
O	1371	1374	had
O	1375	1379	more
O	1380	1385	sleep
O	1386	1394	problems
O	1394	1395	;
O	1396	1399	the
O	1400	1404	MBSR
O	1405	1410	group
O	1411	1414	had
O	1415	1416	a
O	1417	1430	significantly
O	1431	1438	smaller
O	1439	1447	increase
O	1448	1450	in
B-outcome	1451	1456	sleep
I-outcome	1457	1465	problems
O	1466	1470	than
O	1471	1474	the
O	1475	1482	control
O	1483	1488	group
O	1488	1489	.

O	1490	1495	After
O	1496	1499	the
O	1500	1502	12
O	1502	1503	-
O	1503	1508	month
O	1509	1515	follow
O	1515	1516	-
O	1516	1518	up
O	1518	1519	,
O	1520	1525	there
O	1526	1529	was
O	1530	1532	no
O	1533	1544	significant
O	1545	1552	between
O	1552	1553	-
O	1553	1558	group
O	1559	1565	effect
O	1566	1568	of
O	1569	1573	MBSR
O	1574	1576	on
B-outcome	1577	1582	sleep
I-outcome	1583	1590	quality
O	1591	1593	in
O	1594	1603	intention
O	1603	1604	-
O	1604	1606	to
O	1606	1607	-
O	1607	1612	treat
O	1613	1621	analyses
O	1621	1622	.

O	1623	1627	MBSR
O	1628	1631	had
O	1632	1633	a
O	1634	1647	statistically
O	1648	1659	significant
O	1660	1666	effect
O	1667	1669	on
B-outcome	1670	1675	sleep
I-outcome	1676	1683	quality
O	1684	1688	just
O	1689	1694	after
O	1695	1698	the
O	1699	1711	intervention
O	1712	1715	but
O	1716	1718	no
O	1719	1723	long
O	1723	1724	-
O	1724	1728	term
O	1729	1735	effect
O	1736	1741	among
O	1742	1748	breast
O	1749	1755	cancer
O	1756	1764	patients
O	1764	1765	.

O	1766	1772	Future
O	1773	1779	trials
O	1780	1782	in
O	1783	1788	which
O	1789	1802	participation
O	1803	1805	is
O	1806	1816	restricted
O	1817	1819	to
O	1820	1828	patients
O	1829	1833	with
O	1834	1845	significant
O	1846	1851	sleep
O	1852	1860	problems
O	1861	1864	are
O	1865	1876	recommended
O	1877	1880	for
O	1881	1891	evaluating
O	1892	1895	the
O	1896	1902	effect
O	1903	1905	of
O	1906	1910	MBSR
O	1911	1913	on
O	1914	1919	sleep
O	1920	1927	quality
O	1927	1928	.
